Hologic, US4364401012

Hologic stock heads into the open after a 0.5 percent gain

Published on 09/17/2026 at 07:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 15, 2026, Hologic stock finished at USD 76.01 on the Nasdaq, up 0.5 percent, with the price ending near the top of the day range and slightly ahead of the broader Nasdaq Composite move.

Fotorealistisches Mammographiegerät in hellem klinischem Untersuchungsraum mit Pflegekraft
Hologic zeigt ein Mammographie Gerät in einem modernen klinischen Untersuchungsraum ISIN US4364401012, Illustration mit AI erstellt.

Hologic stock closed at USD 76.01 on the Nasdaq on September 15, 2026, marking a 0.5 percent gain for the session. Per Nasdaq data referenced in recent market coverage, the shares ended the day closer to the session high than to the low, indicating demand into the close.

September 15, 2026 in numbers

Hologic Inc. (ISIN US4364401012, Nasdaq: HOLX) finished the last completed session on the Nasdaq at USD 76.01 on September 15, 2026, up 0.5 percent from the prior close, with the price positioned near the upper end of the intraday range reported in market data. As Ad-hoc-news noted in its recap of the Nasdaq session, the close at USD 76.01 came significantly closer to the day high than to the low, underscoring stable buying interest toward the end of trading. In the same session, the Nasdaq Composite fell modestly, so Hologic slightly outperformed the broader technology-heavy index despite the softer overall market tone reported for September 15, 2026.

Today’s context and upcoming events

Today, September 17, 2026, Hologic enters the pre-market phase without a newly published company earnings report or major scheduled corporate event cited in the latest publicly available calendars. Broader market narratives around United States equities continue to emphasize interest rate policy and macroeconomic data, with recent coverage by DTN/Associated Press highlighting investor focus on Federal Reserve interest rate decisions as a key factor for equity valuations. For a medical technology and diagnostics name like Hologic, movements in the Nasdaq Composite and changes in funding conditions around health care and life sciences can influence sentiment, so traders are likely to watch sector peers and the broader index closely as the United States session on September 17, 2026 begins.

Disclaimer...

en | US4364401012 | HOLOGIC | boerse | 70115341 | bgmi